Enroll in an IgA nephropathy (IgAN) Clinical Trial

IgA nephropathy (IgAN), also known as Berger's disease, is a kidney disease that impacts roughly 60,000 people in the United States. IgAN occurs when an antibody called immunoglobulin A (IgA) builds up in the kidney and causes inflammation, which can hamper the kidneys' ability to filter waste from the blood over time.

Researchers are currently studying an investigational oral drug for IgAN and are seeking clinical trial volunteers. Participants must be over the age of 18 and have had a kidney biopsy that confirms their IgAN diagnosis. If you’re interested, answer a few questions below to check your eligibility.

Check eligibility

Study details

Who is Antidote?

Antidote is a digital health company on a mission to transform the way that sponsors and patients connect in order to accelerate medical research. They are headquartered in the US and the UK.

What is clinical research?

Clinical researchers determine if new interventions, including potential treatments, healthcare technology, healthcare services, and medical devices, are safe and effective for humans. All medications and devices must undergo clinical trials before they are made available to patients. Before anyone can participate in a clinical research trial, they will be asked to review and sign an informed consent form (ICF), which will explain the potential benefits, risks, and side effects that may be experienced while taking part in the clinical trial. Signing it indicates that the individual agrees to take part in this research study.

What's the difference between an observational study and an interventional study?

There are two different kinds of studies in which you can participate. Most common are interventional clinical trials in which people participate to determine whether investigational drugs or treatments are safe and effective for humans. All investigational medications and devices must undergo clinical trials before they are made available.

There are also observational studies, in which researchers ask people with the same disease or treatment plan to be observed over a period of time. During this time, researchers observe how participants are responding to their treatments and take into account different variables that participants might be exposed to.

In some cases, researchers will analyze de-identified medical records to see how a disease affects people in varying geographic locations or with different treatment plans. A patient registry is often a type of observational study used to gain a deeper understanding of a condition.

What motivates someone to participate in a clinical trial?

Study participants receive access to potential new treatments, medical devices, and healthcare services and technologies. By participating, they help everyone living with their condition. They also often get access to better care.

What are the benefits and risks of participating in research?

Each clinical trial or research study comes with its own potential benefits and risks. It's important to discuss these benefits and risks with either your doctor or the clinical trial site contact before making any decisions.

Is participant information kept safe?

Participant information will be kept confidential within the limits of the law of the country in which the trial is conducted. If the results of this clinical trial are published or presented in a meeting, participants will not be named.

Can participants decide to leave a trial?

Participants can decide to leave a clinical trial or research study at any time, for any reason. There is no charge or penalty for deciding not to take part in a clinical trial.

If you would like to speak to someone regarding this trial, first check to see if you are initially eligible through the prescreener above. If it seems that you are eligible to take part, you will be contacted by phone so we can ask you additional questions to confirm your eligibility, and you will be able to ask any questions you may have about this clinical trial. If you are not eligible based on your responses to the prescreener, you can always contact us at patientsupport@antidote.me to discuss further.

Click here to share this trial.